Quality of life in patients with recurrent ovarian cancer treated with niraparib versus placebo (ENGOT-OV16/NOVA): results from a double-blind, phase 3, randomised controlled trial
Title:
Quality of life in patients with recurrent ovarian cancer treated with niraparib versus placebo (ENGOT-OV16/NOVA): results from a double-blind, phase 3, randomised controlled trial
Author:
Oza, Amit M Matulonis, Ursula A Malander, Susanne Hudgens, Stacie Sehouli, Jalid del Campo, Josep M Berton-Rigaud, Dominique Banerjee, Susana Scambia, Giovanni Berek, Jonathan S Lund, Bente Tinker, Anna V Hilpert, Felix Vázquez, Isabel Palacio D'Hondt, Véronique Benigno, Benedict Provencher, Diane Buscema, Joseph Agarwal, Shefali Mirza, Mansoor R